Click a keyword to view all the abstracts on this site tagged with that keyword.
- Biosimilars and rheumatoid arthritis (RA)
- Biosimilars and rituximab
- biosimilars and safety
- Biostatistics
- bipolar disorder and mood disorder questionnaire
- Bisphosphonates
- bisphosphonates and denosumab
- bisphosphonates and infliximab
- bisphosphonates and osteoarthritis
- bisphosphonates and osteoporosis
- Bisphosphonates and pregnancy
- BK virus
- Blau syndrome
- bleomycin
- blindness
- blood brain barrier
- blood pressure
- BLyS
- BLyS and Lupus
- BLyS and systemic lupus erythematosus (SLE)
- BMD
- bmi
- BMI and obesity
- bmi and physical activity
- bmp and chondrocytes
- body composition
- Body image
- body image and quality of life
- Body image and systemic sclerosis
- body mass
- Body mass and disability
- body mass and etanercept
- body mass and hip disorders
- body mass and inflammation
- Body mass and juvenile idiopathic arthritis (JIA)
- body mass and obesity
- Body mass and osteoporosis
- body mass and Personalized Medicine
- body mass and pharmacokinetics
- body mass and prognostic factors
- body mass and psoriatic arthritis
- body mass and rheumatoid arthritis (RA)
- body mass and tumor necrosis factor (TNF)
- BOLD
- Bone
- Bone and gout
- Bone and imaging techniques
- Bone and inflammation
- Bone and magnetic resonance imaging (MRI)
- Bone and osteoblasts
- Bone and prognostic factors
- Bone and sarcoidosis
- Bone and uric acid
- bone attenuation coefficient and vertebral fracture
- bone biology
- bone biology and dendritic cells
- bone biology and rheumatoid arthritis (RA)
- bone biology and WNT Signaling
- Bone density
- bone density and bone quality
- bone density and Cell Migration
- bone density and dual energy x-ray absorptiometry (DEXA)
- bone density and fracture risk
- bone density and fractures
- bone density and glucocorticoids
- Bone density and metabolic syndrome
- Bone density and osteoarthritis
- bone density and osteoporosis
- Bone density and physical activity
- bone density and psoriatic arthritis
- bone density and radiography
- bone density and radiology
- Bone density and rheumatoid arthritis (RA)
- bone density and risk
- bone density and sarcopenia
- Bone density and spondylarthropathy
- bone density and steroids
- Bone density and systemic lupus erythematosus (SLE)
- bone density and treatment
- Bone density and uric acid
- bone disease
- bone disease and genetic disorders
- bone disease and imaging techniques
- bone disease and osteoclastogenesis
- bone disease and osteoporosis
- bone disease and rheumatoid arthritis (RA)
- bone disease and treatment
- bone disease and x-ray
- Bone erosion
- bone formation and adenosine receptors
- bone health
- Bone marrow
- bone marrow and interferons
- bone marrow and macrophage activation syndrome
- bone marrow and osteoarthritis
- Bone marrow and osteoclasts
- bone marrow and rheumatoid arthritis (RA)
- Bone marrow and scleroderma
- bone marrow and systemic lupus erythematosus (SLE)
- bone marrow lesions
- bone marrow lesions and diagnostic imaging
- bone marrow lesions and inflammation
- bone marrow lesions and osteoarthritis
- bone marrow lesions and rheumatoid arthritis (RA)
- bone metabolism
- bone metabolism and bone remodeling mediators
- Bone metabolism and rheumatoid arthritis (RA)
- Bone metabolism and spondylarthritis
- Bone mineral density
- bone mineral density and frailty
- bone remodeling
- bone remodeling and biopsies
- bone remodeling and fractures
- bone remodeling and prostaglandins
- bone remodeling and rheumatoid arthritis (RA)
- bone remodeling and spondylarthropathy
- Bone Resorption
- Bone turnover markers
- bone turnover markers and bone density
- bone turnover markers and inflammation
- bone turnover markers and modified stoke ankylosing spondylitis spinal score (MSASSS)
- Bone turnover markers and systemic lupus erythematosus (SLE)
- Bortezomib
- Bortezomib and SLE
- botulinum toxin
- botulinum toxin and pain management
- botulinum toxin and treatment
- Bowel
- BR3
- Brain
- Brain Biopsy
- Brain-derived neurotrophic factor
- Brain-derived Neurotrophic Factor and Neuropsychological Assessment
- BRD4 and systemic sclerosis
- Breastfeeding
- Brief Pain Inventory
- Brodalumab
- Bromodomain
- bronchoalveolar lavage fluid and morbidity and mortality
- BTK
- BTK and rheumatoid arthritis (RA)
- Burden of Adverse Drug Reactions
- bursal puncture
- business
- business and rheumatoid arthritis (RA)
- C protein-induced myositis
- C Reactive Protein
- C Reactive Protein and synovitis
- C-reactive protein (CRP)
- C-reactive protein (CRP) and Aging
- C-reactive protein (CRP) and autoantibodies
- C-reactive protein (CRP) and Disease Activity
- C-reactive protein (CRP) and interleukins (IL)
- C-reactive protein (CRP) and laboratory and imaging evaluation
- C-reactive protein (CRP) and renal disease
- C-reactive protein (CRP) and rheumatoid arthritis (RA)
- C-reactive protein (CRP) and scleroderma
- C1q
- C1q and systemic lupus erythematosus (SLE)
- C4 gene
- C4B gene
- C4BL gene
- cachexia and myostatin
- cadherin-11
- Cadherins
- calcinosis
- calcinosis and dermatomyositis
- Calcinosis and juvenile dermatomyositis
- calcinosis and pyrophosphate
- Calcinosis and scleroderma
- Calcinosis and systemic sclerosis
- Calcinosis and treatment
- Calcitonin
- Calcium
- calcium and cardiovascular disease
- Calcium and denosumab
- Calcium and mesenchymal stem cells
- calcium and rheumatoid arthritis (RA)
- calcium and signal transduction
- calcium and tendonitis/bursitis
- Calcium and vasculitis
- Calcium pyrophosphate dihydrate (CPPD)
- Calcium pyrophosphate dihydrate (CPPD) and chondrocytes
- Calcium pyrophosphate dihydrate (CPPD) and diagnosis
- calcium pyrophosphate dihydrate (CPPD) and Electronic Health Record
- Calcium pyrophosphate dihydrate (CPPD) and pseudogout
- Calcium pyrophosphate dihydrate (CPPD) and rheumatoid arthritis (RA)
- Calcium pyrophosphate dihydrate (CPPD) and synovial fluid
- calcium pyrophosphate dihydrate (CPPD) and ultrasound
- calcium signaling
- Calgranulin
- CALIPER and survival
- calprotectin
- calprotectin and atherosclerosis
- calprotectin and longitudinal studies
- CaMKIV and Treg
- canakinumab
- canakinumab and Biologics
- Canakinumab and caregivers
- canakinumab and corticosteroids